亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

潑尼松龍

 
 
單價 面議對比
詢價 暫無
發貨 湖北武漢市付款后3天內
過期 長期有效
更新 2011-04-16 11:44
 

武漢遠城科技發展有限公司銷售八部

企業會員第16年
資料未認證
保證金未繳納
詳細說明
潑尼松龍 
英文名稱:prednisolone 
CAS 編號:50-24-8 
包裝規格:25kg/紙板桶 
規格型號:99%  
中文別名:氫化潑尼松; 強的松龍; 去氫氫化可的松 
英文名稱:prednisolone 
英文別名:11-beta,17-alpha,21-trihydroxypregna-1,4-diene-3,20-dione 
分 子 式: C21H28O5 
分子量: 360.45 
產品用途: 適用于類風濕關節炎、風濕熱、紅斑狼瘡、皮肌炎、多發性骨髓瘤等 
prednisolone
CAS No. :50 -24-8
Packing: 25kg / cardboard drum
Specification: 99%
Chinese alias: prednisolone; prednisolone; dehydrogenase hydrocortisone
English name: prednisolone
English Name :11-beta ,17-alpha ,21-trihydroxypregna-1 ,4-diene-3 ,20-dione
Molecular formula: C21H28O5
MW: 360.45
Usage: Suitable for rheumatoid arthritis, rheumatic fever,
 lupus erythematosus, dermatomyositis, multiple myeloma, etc.
舉報收藏 0評論 0
更多>本企業其它產品
氯唑沙宗 羅非昔布 美羅培南 美洛昔康 美索巴莫 尼美舒利 帕馬溴
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |